Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642355 · ClinicalTrials.gov registry record · NA
Prevention Trial to Achieve Cardiovascular Targets
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT01642355 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 400 participants.
The verdict
NCT01642355, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The objective of IMPACT (Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets) is to determine the best management strategy for patients undergoing cardiovascular intervention. IMPACT is a prospective randomized trial that will enroll 400 patients post-cardiovascular intervention. The study will compare different cardiovascular prevention strategies: (1) usual care, (2) cardiovascular prevention consult, and (3) cardiovascular prevention consult with a behavioral intervention program over a 6-month period. The trial hypothesis is that for patients undergoing a cardiovascular intervention, a prevention consult and behavioral intervention is superior to usual care in reducing cardiovascular risk. The primary endpoint will be non-HDL cholesterol. Secondary endpoints include other lipid values, metabolic risk, smoking cessation, physical activity, nutritional status, medication adherence and quality of life. IMPACT is scheduled to begin enrollment in the June of 2012.
Interventions
- BEHAVIORAL Prevention Consult
- BEHAVIORAL Consult & Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01642355
The ClinicalTrials.gov registry entry for NCT01642355 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevention Consult is the first listed.
NCT01642355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01642355 about?
NCT01642355 is a clinical study titled "Prevention Trial to Achieve Cardiovascular Targets". The objective of IMPACT (Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets) is to determine the best management strategy for patients undergoing cardiovascular intervention. IMPACT is a prospective randomized trial that will enroll 400 patients post...
What is the current status of trial NCT01642355?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2012-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01642355?
The interventions under investigation include: Prevention Consult (BEHAVIORAL), Consult & Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01642355?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.